Modulation of cancer endocrine therapy by melatonin: a phase II study of tamoxifen plus melatonin in metastatic breast cancer patients progressing under tamoxifen alone.

Benzer Materyaller

• A phase II study of tamoxifen plus melatonin in metastatic solid tumour patients.
  Yazar:: Lissoni, P., ve diğerleri
  Baskı/Yayın Bilgisi: (1996)
• A randomised study with subcutaneous low-dose interleukin 2 alone vs interleukin 2 plus the pineal neurohormone melatonin in advanced solid neoplasms other than renal cancer and melanoma.
  Yazar:: Lissoni, P., ve diğerleri
  Baskı/Yayın Bilgisi: (1994)
• Immunotherapy with subcutaneous low-dose interleukin-2 and the pineal indole melatonin as a new effective therapy in advanced cancers of the digestive tract.
  Yazar:: Lissoni, P., ve diğerleri
  Baskı/Yayın Bilgisi: (1993)
• Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
  Yazar:: Wilcken, Nicholas, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer
  Yazar:: Goetz, Matthew P., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)